Fixed-dose combination tablets integrating sustained-release metformin with glimepiride and voglibose for type 2 diabetes management. Pharmaceutical manufacturers supply to wholesalers and hospitals, where procurement teams acquire for endocrinologists in outpatient clinics and retail pharmacies for patient distribution.